Catalent Pharma Solutions has announced it has completed an expansion project at its Kansas City facility to significantly increase controlled-temperature storage capabilities for its clinical supply business.
The expansion added 70,000ft³ of storage (2°C-8°C) at the site, representing a five-fold increase in controlled-temperature capacity. This is made up of a combination of both pallet and high-density storage options to increase flexibility. To support growing customer demand, two secondary cold packaging areas have been added, with the option to add more as needed.
Catalent’s General manager of the site’s clinical supply services Tom Moon said: "Customers have benefitted from our Kansas City campus’ integrated analytical, oral solid manufacturing, and clinical supply services, and now we can offer them expanded cold storage and packaging services as well.
"In the past 18 months, we seen an increase in the numbers of both large and small customers, and to meet this growing demand have nearly doubled our clinical supply workforce, as well as introduced additional shifts in both packaging and distribution."
Catalent’s 450,000ft² Kansas City facility provides a range of fully integrated services, from development and analytical support through to packaging and distribution. In 2015, the site completed an investment project that expanded its high-potent and cytotoxic clinical drug packaging capabilities.
Catalent has also recently announced investment and expansions to its workforce in its clinical supply network at Bolton and Bathgate in the UK, and in Singapore.